Rate My Professor Amit Bhatia

Dr. Amit Bhatia serves as Professor and Head of the Department of Pharmaceutical Sciences and Technology at Maharaja Ranjit Singh Punjab Technical University (MRSPTU) in Bathinda, Punjab, India. He earned his B.Pharm., M.Pharm. in Pharmaceutics, and Ph.D. in Pharmaceutical Sciences from Panjab University, Chandigarh. With more than 12 years of combined teaching and research experience, his career includes positions as teaching faculty at Panjab University, Lovely Professional University in Phagwara, and Amity University in Noida. Earlier, he worked as a research scientist at Sun Pharmaceutical Advanced Research Centre in Vadodara, focusing on formulation research and development. Dr. Bhatia has also held administrative roles such as coordinator for the division of Academic Affairs at Lovely Professional University and additional director for the domain of health and allied sciences at Amity University. He has contributed to curriculum designing, outcome-based teaching, regulatory inspections of pharmacy institutions for the Punjab State Board of Technical Education and Industrial Training, and MRSPTU governance.

Dr. Bhatia's research centers on drug delivery systems and strategies, translational research including scale-up and technology transfer, systematic optimization in formulation development, trouble shooting, process improvement, oral, ophthalmic, and topical formulations, and regulatory affairs. He has published 42 research and review articles in prestigious journals, garnering over 3,610 citations according to Google Scholar. Key publications include 'PLGA: a unique polymer for drug delivery' (Therapeutic Delivery, 2015, 716 citations), 'Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation' (J Pharm Pharm Sci, 2004, 239 citations), 'Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment' (AAPS PharmSciTech, 2017, 233 citations), and 'C60-fullerenes for delivery of docetaxel to breast cancer cells: a promising approach for enhanced efficacy and better pharmacokinetic profile' (International Journal of Pharmaceutics, 2015, 178 citations). He holds 3 granted patents and 4 published ones, and has been part of teams commercializing novel drug delivery products. Dr. Bhatia received the Young Nanotechnologist award from the National Institute of Pharmaceutical Education and Research (NIPER), Mohali. He has guided 2 PhD scholars and 24 postgraduate students, and currently supervises 5 PhD and 4 PG students. His research projects include ASEAN-India collaborative efforts funded by the Department of Science and Technology, an ad-hoc project by the Indian Council of Medical Research, and two from the Punjab State Council for Science and Technology. As a reviewer for international journals and conferences, he has delivered invited lectures and presented at global events, influencing advancements in pharmaceutical formulation and delivery.